Increasing capacity to accelerate your breakthroughs
Choosing the right partner for analytical, bioassay, and biosafety testing is critical in the race to therapy approval. Our BioReliance® testing services bring testing closer to where you need it, expanding our offering with exceptional technical and regulatory expertise in Europe to help you bring life-changing therapies to patients.
Bring testing closer to your patients. Speak with our team today.
This new 2,000 m² BioReliance® contract testing site in Darmstadt, Germany, set to open in early 2027, is designed around your testing needs by providing reliable, high-quality testing solutions, including:
- GMP drug substance and drug product release testing: Ensuring compliance with regulatory guidelines prior to releasing your therapies for clinical trials or into global pharmaceutical markets.
- Stability studies: GMP-compliant testing services for stability programs tailored to meet the unique needs of your therapy.
Benefit from harmonized quality systems across our global network: Reliable, timely, GMP-compliant testing from the very first sample. You get the gold-standard of the BioReliance® services quality system within the European Union.
Facts and figures
25 M€
Investment
2,000 m²
Contract testing facility
75+ years
Biosafety testing experience
Opening
Expected Q1 2027
Your partner for drug product release testing and stability studies
This new contract testing facility in Darmstadt, Germany will service manufacturers worldwide, enabling the release of monoclonal antibody (mAbs) and cell therapy batches in the European Union. Bringing testing closer to your patients, this site will support with:
- Increased testing capacity to accelerate your development
- Seamless integration with our globally connected BioReliance® services network
- A dedicated team of scientists and regulatory experts ready to support your global product development strategy
Why Darmstadt Germany?
Rooted in Darmstadt since 1668, we bring over 350 years of science and quality to the world
A Darmstadt location means direct access to Europe's biopharma clusters, reducing logistics complexity via our sample concierge services and keeping your program aligned with EMA expectations.
Why reserve now?
Pre-opening slot holders receive priority scheduling, dedicated method transfer support, and early access to our team.
Priority scheduling to align to your program’s needs support on-time delivery of GMP testing results.
Our comprehensive offering enables assessment of all the quality attributes that need to be analysed for DS and DP, using combinations of off-the-shelf, compendial and platform methods complemented with support for establishment or transfer of your product-specific assays.
Secure your slot at our new contract testing facility. Reach out to our team of experts to learn more about how to book your pre-opening slot today.
Explore services offered at the BioReliance® services site in Germany
Related resources
- Flyer: Expert partnership contract testing services
Discover comprehensive services support your development journey.
- Flyer: Next generation sequencing in biosafety testing & product characterization"
Learn about regulatory support for the use of NGS methods.
- Flyer: Accelerating CHO bulk harvest testing requires rapid methods
An alternative to the in vitro virus assay for bulk harvest material.
- Flyer: Leave no gap in your AAT strategy
De-risk IND filings with a complete adventitious agent testing (AAT) package.
- Flyer: Ensure complete characterization of your rodent cell line.
The Blazar® tNGS Rodent Virus Panel detects species-specific viruses during cell line characterization
- Flyer: Discover cell line NGS AAT enhanced
Keep regulatory confidence, gain modern objectivity for your cell line characterization.